Metfo XR 1000mg

Metfo XR 1000mg — Metformin Hydrochloride 1000 mg + Sitagliptin 100 mg ER Tablet

What Is Metfo XR 1000mg?

Metfo XR 1000mg is a fixed-dose combination tablet containing extended-release metformin hydrochloride 1000 mg and sitagliptin 100 mg, manufactured by Pacific Pharmaceuticals Ltd. Unlike the plain metformin Metfo tablets, this product combines two different classes of antidiabetic medicine in a single once-daily tablet, intended for patients who need more than metformin alone provides.

Why a Combination Tablet?

Combining metformin with sitagliptin, a DPP-4 inhibitor, allows two complementary mechanisms to work together: metformin reduces glucose production by the liver and improves insulin sensitivity, while sitagliptin boosts the body's own incretin hormone activity to increase insulin release after meals and reduce glucagon levels. This combination is typically prescribed when metformin alone has not achieved adequate blood glucose control, sparing patients from taking two separate tablets.

Mechanism of Action

Metformin works by decreasing hepatic glucose output and improving peripheral insulin sensitivity. Sitagliptin inhibits the DPP-4 enzyme, which prolongs the activity of incretin hormones (GLP-1 and GIP), leading to glucose-dependent insulin secretion and suppressed glucagon release. Together, they provide a more comprehensive glycemic control than either drug alone.

Indications

Metfo XR 1000mg is indicated for type 2 diabetes mellitus in adults who require combination therapy with metformin and a DPP-4 inhibitor to improve glycemic control, typically after metformin monotherapy has proven insufficient.

Dosage and Administration

The tablet is usually taken once daily with the evening meal, as prescribed by your physician. Because it is an extended-release formulation, the tablet must be swallowed whole — do not crush, split, or chew it, as this can affect the controlled release of metformin.

Contraindications

Avoid use in patients with severe renal impairment, metabolic acidosis (including diabetic ketoacidosis), known hypersensitivity to metformin or sitagliptin, or a history of serious allergic reactions to DPP-4 inhibitors such as severe skin reactions or angioedema.

Side Effects

Common side effects include gastrointestinal symptoms from the metformin component (nausea, diarrhea, abdominal discomfort) and, less commonly, headache, upper respiratory symptoms, or joint pain associated with sitagliptin. Rare but serious risks include pancreatitis and lactic acidosis — seek medical attention for severe abdominal pain or unusual fatigue and muscle pain.

Drug Interactions

Inform your doctor of all medicines you take, especially other antidiabetic drugs (to avoid excessive blood glucose lowering), iodinated contrast agents, and drugs affecting renal clearance. Combining with sulphonylureas or insulin may increase hypoglycemia risk and require dose adjustment of those agents.

Special Populations

Renal function must be assessed before starting and monitored periodically, as both components require dose consideration in renal impairment. Use in pregnancy and breastfeeding should be guided by a specialist. Not recommended for patients with type 1 diabetes or diabetic ketoacidosis.

Storage

Store below 30°C in a dry place away from light. Keep out of reach of children.

Frequently Asked Questions

Q1: How is Metfo XR 1000mg different from regular metformin?

This tablet combines extended-release metformin with sitagliptin, a second antidiabetic medicine that works through a different mechanism. It is prescribed when metformin alone isn't providing sufficient blood glucose control.

Q2: Can I take this tablet at any time of day?

It's typically recommended with the evening meal for consistent absorption, but follow your doctor's specific instructions, as timing may vary based on your individual treatment plan.

Q3: Will this combination cause low blood sugar?

The combination of metformin and sitagliptin carries a low risk of hypoglycemia on its own, but risk increases if combined with other antidiabetic medicines like sulphonylureas or insulin. Discuss your full medication regimen with your doctor.

Q4: What if I experience severe stomach pain while taking this medicine?

Severe or persistent abdominal pain could indicate pancreatitis, a rare but serious side effect associated with DPP-4 inhibitors. Stop the medication and seek medical attention promptly if this occurs.

Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice. Always consult a qualified physician before starting, stopping, or changing any medication. Use only as prescribed.